|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4725 | |
| A61K 31/4178 | |||
| A61K 31/55 | |||
| A61P 31/12 | |||
| A61P 31/14 |
| (11) | Patento numeris | 2600835 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11815206.5 |
| Europos patento paraiškos padavimo data | 2011-08-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-06-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-05-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/046285 |
| Data | 2011-08-02 |
| (87) | Numeris | WO 2012/018829 |
| Data | 2012-02-09 |
| (30) | Numeris | Data | Šalis |
| 371399 P | 2010-08-06 | US |
| (72) |
GAO, Min, US
GARDINER, David F., US
LEMM, Julie A., US
MCPHEE, Fiona, US
VOSS, Stacey A., US
|
| (73) |
Bristol-Myers Squibb Holdings Ireland,
Hinterbergstrasse 16, 6312 Steinhausen,
CH
|
| (54) | COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS |
| COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS |